Avelumab in Refractory Testicular Germ Cell Cancer.

Conditions:   Testicular Neoplasms;   Neoplasms, Germ Cell and Embryonal;   Neoplasms;   Testicular Diseases;   Gonadal Disorders;   Antineoplastic Agents;   Molecular Mechanisms of Pharmacological Action Intervention:   Drug: Avelumab Sponsors:   National Cancer Institute, Slovakia;   Merck Sharp & Dohme Corp. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials